(University of Missouri-Columbia) In a first-of-its-kind study, scientists at the University of Missouri have helped advance a patient-specific, precision medicine treatment for bone cancer in dogs. By creating a vaccine from a dog's own tumor, scientists worked with ELIAS Animal Health to target specific cancer cells and avoid the toxic side effects of chemotherapy, while also opening the door for future human clinical trials.
from EurekAlert! - Social and Behavioral Science http://bit.ly/2B9da7r
No comments:
Post a Comment